TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer.
Saved in:
| Title: | TRF2 interaction with nuclear envelope is required for cell polarization and metastasis in triple negative breast cancer. |
|---|---|
| Authors: | Petti E; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Di Vito S; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy.; Department of Ecological and Biological Sciences (DEB), University of Tuscia, Viterbo, Italy., Dinami R; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Porru M; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Marchesi S; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Lohuis J; Division of Molecular Pathology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands., Zizza P; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Iachettini S; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Salvati E; Institute of Molecular Biology and Pathology, National Research Council, Rome, Italy., D'Angelo C; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Rizzo A; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Maresca C; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Ascione F; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy., Di Benedetto A; Department of Pathology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Buglioni S; Department of Pathology, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Sacconi A; UOSD Clinical Trial Center, Biostatistics and Bioinformatics, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., Ostano P; Cancer Genomics Lab, Fondazione Edo ed Elvo Tempia, Biella, Italy., Li Q; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy., Stoppacciaro A; Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy., Leonetti C; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy., van Rheenen J; Division of Molecular Pathology, Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands., Maiuri P; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Molecular Medicine and Medical Biotechnology, Università degli Studi di Napoli 'Federico II', Naples, Italy., Scita G; IFOM ETS-The AIRC Institute of Molecular Oncology, Milan, Italy.; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy., Biroccio A; Translational Oncology Research Unit, IRCCS-Regina Elena National Cancer Institute, Rome, Italy. annamaria.biroccio@ifo.it. |
| Source: | Cell death & disease [Cell Death Dis] 2025 Mar 30; Vol. 16 (1), pp. 224. Date of Electronic Publication: 2025 Mar 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
